Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands,
The M&A scramble for Europe has continued at a fearsome pace over the last few weeks. Organigram has closed its
Cannabis stocks have once again been sent flying in the wake of the latest hint of progress on cannabis rescheduling
Cannabis stocks enjoyed another spike last week following reports that the Centers for Medicare & Medicaid Services is preparing to
Cannabis Stocks Surge on Trump Video Global cannabis stocks have enjoyed a considerable, but likely temporary, run this week, after
Portuguese cultivators have welcomed moves by the country’s police to crack down on a criminal gang using loopholes in its medical cannabis laws to cultivate and illegally export around £15m of product.
Tilray [stock_market_widget type=”chart” template=”line” assets=”TLRY” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] The international cannabis giant
Tilray’s stock price has tumbled some 24% since the start of the week as its Q3 2025 financial figures failed
Stenocare Danish medical cannabis oil producer Stenocare has exited its cultivation facility in Denmark, just four years after it was
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.AX” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent Biopharma (previously
Akanda Corp [stock_market_widget type=”chart” template=”line” assets=”AKAN” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] NASDAQ-listed international medical
Young US women are consuming more cannabis than men for the first time, according to recently published data from the US National Institute on Drug Abuse (NIDA).
Canadian medical cannabis clinic Santé Cannabis has started recruitment for a new study assessing the effectiveness of various cannabis treatment plans.
Tilray’s cannabis revenues fell sharply over its first quarter, but its overall revenues were up 13% thanks to a near doubling in revenues from its alcohol business.
Canadian cannabis sales have continued their mixed performance through June 2024, seeing another dip in total sales, but some states
Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has now issued the first three new licences for domestic cannabis
Tilray [stock_market_widget type=”chart” template=”line” assets=”TLRY” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] US cannabis giant Tilray
Tilray’s medical cannabis division has today published a new scientific study showing significant improvements in pain, sleep and quality of
We won’t spam you
